Results 101 to 110 of about 32,129 (220)

Immune Checkpoint Inhibitor Pneumonitis Complicated by Invasive Pulmonary Aspergillosis in COPD: Diagnostic and Therapeutic Challenges

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Checkpoint inhibitor‐associated pneumonitis complicated by invasive pulmonary aspergillosis represents a diagnostic challenge in ICI‐treated patients, particularly those with COPD receiving corticosteroid therapy. Persistent or worsening respiratory abnormalities despite immunosuppressive treatment should prompt reassessment for superimposed ...
Chukwuka Elendu, Ayi T. Debua, Emeka H. Okolo, Halimat O. Sadiq   +3 more
wiley   +1 more source

Voriconazole Induced Bradycardia

, 2013
Voriconazole is a triazole antifungal drug that is used to treat invasive fungal infections, especially aspergillus. Here, we report two children who had severe bradycardia associated with voriconazole at a dose of 12 mg/kg per day.
Celkan, Tiraje, Uludag, Dilek, Eroglu, Ayse Guler, Tuysuz, Gulen, Ozdemir, Nihal   +4 more
core   +1 more source

Evaluation of the tacrolimus drug interaction with voriconazole vs clotrimazole in heart transplant recipients

JHLT Open
Antifungal prophylaxis postheart transplant (HT) may include voriconazole or clotrimazole, which interact with tacrolimus. There is no guidance for tacrolimus adjustment when transitioning from voriconazole to clotrimazole; therefore, this study ...
Elizabeth Posney, PharmD, Chelsea Barry, PharmD, Nathan J. Verlinden, PharmD, Tara Veasey, PharmD   +3 more
doaj   +1 more source

Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemia

Indian Journal of Medical and Paediatric Oncology, 2016
Background: Antifungal prophylaxis (AFP) reduces the incidence of invasive fungal infections (IFIs) during induction therapy of acute myeloid leukemia (AML). Posaconazole is considered the standard of care.
Akash Shah, Prasanth Ganesan, Venkatraman Radhakrishnan, Krishnarathinam Kannan, Rejiv Rajendranath, Vandana Mahajan, Varalakshmi Vijayakumar, Trivadi Ganesan, Tenali Gnana Sagar   +8 more
doaj   +1 more source

Catastrophic Antiphospholipid Syndrome in a Young Female Complicated by Systemic Lupus Erythematosus and Left Atrial Myxoma: A Rare Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Catastrophic antiphospholipid syndrome (CAPS) is a fulminant and rare variant of antiphospholipid syndrome characterized by rapidly progressive multiorgan thrombosis and a high mortality rate. Its diagnosis is often challenging due to overlapping clinical features with sepsis, thromboembolic disorders, and systemic autoimmune diseases.
Nazmin Ahmed, Mohammad Nazrul Hossain, Abdullah Salman, Sabrina Yesmin, S. M. G. Saklayen   +4 more
wiley   +1 more source

Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child [PDF]

, 2005
Voriconazole is increasingly used as a first-line agent for empirical antifungal therapy of prolonged febrile neutropenia in paediatric cancer patients. We describe the case of a 9-year-old patient with stage IV Burkitt lymphoma, who developed pulmonary ...
Aebischer, C.C., Gugger, M., Ammann, R.A., Schmid, R.A., Jaton, K., Aebi, Christoph, Ritz, Nicole, Aebi, C., Ammann, Roland A., Jaton, Katia, Schmid, Ralph A., Casaulta Aebischer, Carmen, Gugger, Mathias, Ritz, N.   +13 more
core   +1 more source

Voriconazole [PDF]

Reactions Weekly, 2020
  +5 more sources

Risk factors for voriconazole-associated hepatotoxicity in patients with liver dysfunction: a retrospective nested case–control study

Frontiers in Pharmacology
IntroductionVoriconazole is widely used to prevent and treat invasive aspergillosis. However, its use is restricted by adverse effects, including acute liver injury (ALI).
Jing Ren, Xinfeng Cai, Wei Ge, Jinlin Guo, Shan Wang, Qinhui Wang, Linna Liu, Le Yang, Qi Yang   +8 more
doaj   +1 more source

Voriconazole metabolism is influenced by severe inflammation: a prospective study [PDF]

, 2017
Item does not contain fulltextBACKGROUND: During an infection or inflammation, several drug-metabolizing enzymes in the liver are down-regulated, including cytochrome P450 iso-enzymes.
Touw, Daan J.; id_orcid, van der Werf, T.S., van den Heuvel, E.R., Kosterink, Jos G. W., Alffenaar, J.C., Kosterink, Jos G W, Alffenaar, J-WC, Span, L.F., Touw, D.J., Kosterink, Jos G. W.; id_orcid, Avest, Mendy ter, Span, Lambert F R, Zijlstra, Jan G., Alffenaar, J.W.C., Avest, M. ter, Alffenaar, Jan-Willem C., Zijlstra, Jan G, Zijlstra, Jan G.; id_orcid, Touw, Daan J., Werf, Tjip S van der, ter Avest, Mendy, ter Avest, M., Heuvel, E.R. van den, Kosterink, J.G.W., Veringa, Anette, Span, Lambert F. R., Span, L.F.R., van der Werf, Tjip S., Touw, Daan J, Veringa, A., Zijlstra, J.G., van den Heuvel, Edwin R., Werf, T.S. van der, Heuvel, ER Edwin van den   +33 more
core   +1 more source

Oral Cryptococcosis due to Naganishia diffluens in a Patient With Thalassemia: A Case Report and a Literature Review

Journal of Clinical Laboratory Analysis, Volume 40, Issue 11, June 2026.
Naganishia diffluens, a rare non‐neoformans cryptococcal species, was identified by PCR sequencing as the causative agent of oral cryptococcosis in a 31‐year‐old Iranian man with β‐thalassemia. This case represents the first documented instance of oral infection by N.
Zahra Yahyazadeh, Zeynab Haseli, Javad Javidnia, Mahdi Abastabar, Eisa Nazar, Hosein Jalali, Mohamad Taghi Hedayati, Hossein Karami, Mohsen Nosratabadi, Lotfollah Davoodi, Seyyed Reza Aghili, Maryam Moazeni, Iman Haghani, Hamid Badali   +13 more
wiley   +1 more source